Delivery Order SPE2DB22D3401-SPE2DB24FT0ND
Award Date 11/7/23
Potential Completion Date 11/8/23
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with ID SPE2DB22D3004|SPE2DB24FNZ12, is for the delivery of Methimazole 5 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $1,200.05 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on January 12, 2024, with a completion date of January 16, 2024. The contract is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery...
- This federal contract award is for the delivery of Methimazole 5 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has a ceiling value of $2,339.24 and a completion date of August 14, 2023. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides 4,560,024,463 Methimazole 5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,334.75 firm fixed-price delivery order has a completion date of February 23, 2023 and was issued under an Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,031.09 Firm Fixed Price Delivery Order is for the supply of 4,560,259,803 units of the prescription medication Methimazole 5 mg tablets. The contract has an ultimate completion date of March 15, 2023. Amerisourcebergen Drug Corp is the prime contractor and holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Methimazole 10 mg Tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award, valued at $1,729.69, is a Firm Fixed Price Delivery Order with a completion date of February 8, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Methimazole 10 mg tablets. The award, valued at $1,413.65, was made by the Defense Logistics Agency (DLA) and has an ultimate completion date of August 23, 2023. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is a delivery order for the pharmaceutical product Methimazole 5 mg tablets, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $24,621.68 and an ultimate completion date of October 30, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical division. This IDC serves as a...
- This federal contract award, valued at $8,379.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methimazole 5 mg tablets, a medication used to treat hyperthyroidism. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued...
- This federal contract award, valued at $14,042.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 180 tablets of Methimazole 10 mg, a medication used to treat hyperthyroidism. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,368.60 firm fixed price delivery order is for the supply of Methimazole 5 mg tablets. The contract has an ultimate completion date of June 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime...